Acadia Pharmaceuticals | ACAD - Modal Dan Cadangan





Modal Dan Cadangan Perubahan Tanggal
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
ALKERMES USD 1.82B 85.86M 2025-12
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Cara Therapeutics USD 27.87M 5.06M 2025-09
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Cytokinetics USD -659.62M 138.5M 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Incyte USD 5.62B 455.37M 2026-03
J&J USD 81.19B 358M 2026-03
Moderna USD 8.65B 680M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Prothena USD 280.47M 14.51M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12